These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24822310)

  • 1. [The challenge of local control in unresectable locally advanced non-small cell lung cancer].
    Barthelemy N; Lennerts E; Meyns M; Duysinx B; Paulus A; Compère C; Bosquée L; Jérusalem G; Coucke P
    Rev Med Liege; 2014; 69 Suppl 1():75-80. PubMed ID: 24822310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential combined modality therapy for stage III non-small cell lung cancer.
    Vokes EE
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex and controversial issues in locally advanced non-small cell lung carcinoma.
    Machtay M; Jeremic B
    Semin Surg Oncol; 2003; 21(2):128-37. PubMed ID: 14508863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
    Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally advanced non-small cell lung cancer: what is the optimal concurrent chemoradiation regimen?
    Videtic GM
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS32-7. PubMed ID: 22614963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis.
    Zhang SL; Han CB; Sun L; Huang LT; Ma JT
    Radiat Oncol; 2020 Aug; 15(1):205. PubMed ID: 32831120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Review of chemoradiotherapy followed by surgical resection in locally advanced non-small-cell lung cancer].
    Futamura Y; Sawa T; Hasegawa T; Horiba A; Ishiguro T; Yoshida T; Kinoshita T; Marui T; Murakami E; Azuma K; Murakawa S; Iida T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2390-2. PubMed ID: 23268087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?
    Bayman N; Blackhall F; McCloskey P; Taylor P; Faivre-Finn C
    Lung Cancer; 2014 Feb; 83(2):117-25. PubMed ID: 24373738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease.
    Rengan R; Maity AM; Stevenson JP; Hahn SM
    Clin Cancer Res; 2011 Jul; 17(13):4192-9. PubMed ID: 21576083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
    Juan O; Sánchez-Hernández A; Vázquez S; Casal J; Firvida JL; Aparisi F; Muñoz J; García-Sánchez J; Gironés R; Lázaro M; Giner V
    Anticancer Res; 2014 Apr; 34(4):1959-66. PubMed ID: 24692732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.
    Salama JK; Vokes EE
    J Clin Oncol; 2013 Mar; 31(8):1029-38. PubMed ID: 23401449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
    Mornex F; Peignaux K; Germain T; Wautot V; Chouaki N; Bourayou N; Tourani JM
    Lung Cancer; 2013 Apr; 80(1):68-74. PubMed ID: 23332163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
    Massabeau C; Rouquette I; Lauwers-Cances V; Mazières J; Bachaud JM; Armand JP; Delisle MB; Favre G; Toulas C; Cohen-Jonathan-Moyal E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):696-702. PubMed ID: 19386436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.